Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Founded in 2018, Kyverna Therapeutics is backed by investors that include Vida Ventures and Westlake Village BioPartners and is headquartered in Berkeley, California.